【国際学会】賀川義規医師がASCO2022で発表しました
2022.06.05
【ASCO2022】賀川義規医師の発表がASCO2022のPoster discussionに選出されました
#3518; Plasma RAS dynamics and anti-EGFR rechallenge efficacy in patients with RAS/BRAF wild-type metastatic colorectal cancer: REMARRY and PURSUIT trials. Kagawa Y, et al.


